These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 36351297)
1. Identification of immune-associated prognostic biomarkers in lung adenocarcinoma on the basis of gene co-expression network. Zhang J; Chen A; Xue Z; Liang C Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):334-346. PubMed ID: 36351297 [No Abstract] [Full Text] [Related]
2. The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma. Gao J; Lu F; Yan J; Wang R; Xia Y; Wang L; Li L; Chang L; Li W Front Immunol; 2022; 13():992626. PubMed ID: 36311724 [TBL] [Abstract][Full Text] [Related]
3. Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration. Zhou H; Bian T; Qian L; Zhao C; Zhang W; Zheng M; Zhou H; Liu L; Sun H; Li X; Zhang J; Liu Y Pathol Res Pract; 2021 Dec; 228():153680. PubMed ID: 34798483 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
5. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle. Tang X; Zhou H; Liu Y Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape. Zhu A; Pei D; Zong Y; Fan Y; Wei S; Xing Z; Song S; Wang X; Gao X Front Oncol; 2023; 13():1199608. PubMed ID: 37409245 [TBL] [Abstract][Full Text] [Related]
7. Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis. Wu Y; Yang L; Zhang L; Zheng X; Xu H; Wang K; Weng X Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205284 [TBL] [Abstract][Full Text] [Related]
8. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma. Chen M; Wang X; Wang W; Gui X; Li Z Front Immunol; 2022; 13():829057. PubMed ID: 35833114 [TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma. Cao K; Ling X; Jiang X; Ma J; Zhu J Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897 [TBL] [Abstract][Full Text] [Related]
10. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma]. Zhou J; Wang X; Li Z; Jiang R Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900 [TBL] [Abstract][Full Text] [Related]
11. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma. Xu Z; Chen C Biomed Res Int; 2021; 2021():6663990. PubMed ID: 34036102 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinoma. Liu T; Liu J; Chen Q; Wu L; Zhang L; Qiao D; Huang Z; Lu T; Hu A; Wang J Medicine (Baltimore); 2024 Sep; 103(38):e39854. PubMed ID: 39312319 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. Shu J; Jiang J; Zhao G Front Immunol; 2023; 14():1177847. PubMed ID: 37583701 [TBL] [Abstract][Full Text] [Related]
14. [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes]. Sun J; Zhang H; Liu H; Dong Y; Wang P Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):591-604. PubMed ID: 37752539 [TBL] [Abstract][Full Text] [Related]
15. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma. Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J Front Immunol; 2023; 14():1217590. PubMed ID: 37492563 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of Fatty Acid Metabolism in Lung Adenocarcinoma to Guide Clinical Treatment. Huang D; Tang E; Zhang T; Xu G Front Immunol; 2022; 13():916284. PubMed ID: 35860256 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis. Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ Front Oncol; 2022; 12():1022097. PubMed ID: 36300102 [TBL] [Abstract][Full Text] [Related]
19. A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma. Liang JX; Chen Q; Gao W; Chen D; Qian XY; Bi JQ; Lin XC; Han BB; Liu JS BMC Bioinformatics; 2022 Dec; 23(1):562. PubMed ID: 36575396 [TBL] [Abstract][Full Text] [Related]
20. Identification of Bian T; Zhang W; Wang F; Chu X; Pan X; Ruan J; Yu S; Liu L; Sun H; Qiu H; Li Y; Tang J; Zhao X; Zhang H Comb Chem High Throughput Screen; 2023; 26(14):2452-2468. PubMed ID: 37038295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]